Cerus | CERS - Cash And Equivalent

Stock Price
2.40
Daily Change
-0.12 -4.58%
Monthly
19.75%
Yearly
80.08%
Q2 Forecast
2.56

Cerus reported $19.96M in Cash and Equivalent for its fiscal quarter ending in December of 2025.





Cash And Equivalent Change Date
Cerus USD 19.96M 4.29M Dec/2025
GRIFOLS EUR 801M 242.31M Dec/2025
Haemonetics USD 363.37M 66.94M Dec/2025
Neogen USD 159.9M 14.56M Dec/2025
OraSure Technologies USD 176.96M 22.31M Mar/2026
Plus Therapeutics USD 4.26M 9.03M Dec/2025
Quidel USD 140.4M 29.4M Mar/2026
Rockwell Medical USD 12.48M 1.09M Jun/2025
STAAR Surgical USD 153.15M 23M Dec/2025
Terumo JPY 217.16B 12.86B Sep/2025
Utah Medical Products USD 84.27M 2.09M Sep/2025